You searched for metabolic diseases - Page 31 of 64

News and Trends 23 Aug 2022

Gate Neurosciences emerges from stealth to tackle CNS diseases

Gate Neurosciences has officially launched to develop its next-generation therapeutics addressing synaptic dysfunction in patients suffering from central nervous system (CNS) disorders. Gate Neurosciences, a U.S. biotech company, was founded…

August 23, 2022 - 3 minutesmins - By Jim Cornall

Interview 3 Mar 2021

The Promises of CRISPR Genome Editing in Biomedicine

…can offer to medicine. For example, it’s critical to move the field beyond therapeutic areas of rare diseases and hematologic malignancies, and into common diseases, like cancer and diabetes, where…

March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 1 Nov 2017

Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis

…give it the power to tackle both well-known and neglected autoimmune diseases that are desperately suffering from an unmet medical need. Apitopes treat autoimmune diseases early on during the inflammation…

November 1, 2017 - 2 minutesmins - By Alex Dale

In Depth 5 May 2023

The biggest private biotech investments in April 2023

…B financing to support phase 1 and 2 trials of its human pluripotent stem cell candidates for lung diseases, degenerative joint diseases, central nervous system (CNS) diseases, and more. Other…

May 5, 2023 - 3 minutesmins - By Willow Shah-Neville

Inflazome Forbion inflammatory disease macrophage

More News! 19 Nov 2018

Anti-Inflammatory Treatments Get €40M Boost in Series B

…factor for many diseases, such as neurodegenerative diseases, autoimmune conditions, and cancer, because it can damage tissue if uncontrolled. One particular inflammasome in Inflazome’s sights is NLRP3. “The NLRP3 inflammasome…

November 19, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 21 Mar 2017

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

…applied to more common diseases. “Whatever we do here, we hope to apply the same tech to diseases that affect more people, like sickle cell anemia and cancer,” says Revah….

March 21, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 17 Oct 2016

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process in neurodegenerative diseases. PhoreMost is a drug discovery company that…

October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2022

Ascidian Therapeutics launches with $50M to rewrite RNA

Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, has been launched. With an initial focus on replacing mutated exons at the RNA level, Ascidian’s technology…

October 12, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

SandboxAQ launches new division to boost drug development

…diseases are enormously complex and defy standard drug design,” said Stanley B. Prusiner, who leads the UCSF Institute for Neurodegenerative Diseases. “We need rational and structure-based design methods that can…

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 26 Sep 2022

Everest Medicines gets go-ahead for renal disease drug study

…of EVER001, a next-generation covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor, in development for the treatment of glomerular diseases. The planned phase 1b clinical study will evaluate the safety, efficacy,…

September 26, 2022 - 2 minutesmins - By Jim Cornall

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

…Sanofi answered some questions from Labiotech.eu about the news for our in-depth newsletter on children’s diseases. When it came to finding a solution, what were the steps involved, and how…

November 14, 2022 - 9 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

The challenges of tackling dementia in women

…comes to addressing women’s health. Dementia is a leading cause of death in women, but it doesn’t get the attention of other diseases, such as breast cancer. Why do you…

March 8, 2023 - 5 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Gate Neurosciences emerges from stealth to tackle CNS diseases

The Promises of CRISPR Genome Editing in Biomedicine

Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis

The biggest private biotech investments in April 2023

Anti-Inflammatory Treatments Get €40M Boost in Series B

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Ascidian Therapeutics launches with $50M to rewrite RNA

SandboxAQ launches new division to boost drug development

Everest Medicines gets go-ahead for renal disease drug study

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

The challenges of tackling dementia in women

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!